Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
about
Association between anthropometry-based nutritional status and malaria: a systematic review of observational studiesThe Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian AmazonKilling the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivaxImplications of Plasmodium vivax Biology for Control, Elimination, and ResearchMajor burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance studyAssessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern IndonesiaThe Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with MalariaTowards a strategy for malaria in pregnancy in Afghanistan: analysis of clinical realities and women's perceptions of malaria and anaemiaGlobal Epidemiology of Plasmodium vivaxThe fluid management of adults with severe malariaA case of vivax malaria complicated by adult respiratory distress syndrome and successful management with extracorporeal membrane oxygenation.Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia.Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malariaPlasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infectionsDefining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles.Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome.Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of NepalRecombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiencyPlasmodium vivax Induced Acute Respiratory Distress Syndrome - A Diagnostic and Therapeutic Dilemma in Preeclampsia.Asia-Pacific malaria is singular, pervasive, diverse and invisibleDynamics of Plasmodium vivax sporogony in wild Anopheles stephensi in a malaria-endemic region of Western IndiaInfluence of age on the haemoglobin concentration of malaria-infected patients in a reference centre in the Brazilian Amazon.Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysisGlobal extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.Malaria-induced splenic infarction.Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.The importance of pathogen load.The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.The prognostic utility of bedside assessment of adults hospitalized with malaria in Myanmar: a retrospective analysis.Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cellsIncidence of Jaundice in Plasmodium vivax Malaria: A Prospective Study in Moodabidri, South India.Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.Malaria and immunity during pregnancy and postpartum: a tale of two speciesOrigins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.Malaria eradication and elimination: views on how to translate a vision into realityExpression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.Plasmodium vivax Transmission in Africa.A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein InteractionsSensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination.Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years.
P2860
Q26786117-CFDF5480-95FA-46A7-A401-24BDF35F3DCBQ27009149-B032C1EA-2815-4B3B-A7E8-14CAB596B056Q28081463-DB7A5BDE-D0B3-411F-BED2-3DCB5A184018Q28355362-21777AE5-A7F2-4C3E-A2C4-8EF9EB36AB5CQ28537653-8C933246-5939-408D-9EC8-0359C5C383CAQ28550280-F394FE2F-B1C6-4277-B6B9-B345563A2D44Q28551039-E74DA42D-4BBA-434A-A019-36114CFBA3FCQ28607891-B7A96729-DC6F-4278-B824-D429541DDFA4Q30249044-DD15260B-53F6-4CF7-9B26-BC2E4DF01E35Q30619692-E1B588E6-8653-4A8B-9101-F54B952B0FCEQ33412049-CC620ED9-CE44-458B-B0EE-B927A7FC8504Q33417944-C2B6F412-CB8E-4718-A2DE-5E512B324CF9Q33419656-4279F6E4-728D-4667-A950-58D8367FA41CQ33435123-5E156B8B-8A6B-4C25-AD43-9B24338594E3Q33563151-B0F19569-1668-4E81-B418-4BD86F452D98Q33713142-1118A6EA-688F-4E2D-A323-C196D3701049Q33721887-AEAD2A97-7799-4D0B-8516-9D6121134EF7Q33731882-F974129E-35F8-4373-AD0D-9E6247F38788Q33741840-4265B641-73A6-4D72-8ECA-F48235F37F66Q33828552-838031E2-7A70-4B47-ACAB-75B5E038F5DBQ33891805-F1EB1FC6-93E3-468E-9D6D-0357059E39ADQ34142735-56CD81EE-8BF3-40F2-991B-2AC064B3AD9BQ34234390-41D4383E-9F70-4A71-9CE1-E5AF7093B1E0Q34259032-BBDC9E7F-3C90-4790-9E37-2066F0279D2AQ34640080-F6EC9E67-593A-47B9-AAEC-222A1223C77DQ34686612-63576FFD-18A7-4468-88CC-79648640852FQ34874961-D5D2A310-40A8-4621-8480-5D4AD0A87C27Q34969275-D929EF72-0468-42CB-A7B9-0F6A12DFA870Q35068767-C1604F57-57D4-4093-A8FE-7F6616E7A2A8Q35328856-6B07EF47-0141-4FC0-A052-B32A32785F65Q35564511-F111C5C0-0381-4B1B-9939-6CFF482C6ED6Q35649424-C561DD26-EE2A-4919-940F-CDBAA5F9F1FBQ35678578-3427B860-0700-4D7F-A0CE-794E31D9FA06Q35682623-37183836-8CF3-4259-A699-E0384A2FC7E5Q35712522-2B8FEF7F-5036-4FD3-9D4A-C10599F30FEDQ35829555-29605955-C385-47ED-AB27-260E7C305DCDQ35847037-570F834E-D706-44E8-B2B1-BB1978C49778Q35877857-CE7D74C0-FEB8-451C-A528-1FA6337035A6Q35921902-CB460F02-31C6-45EA-BEED-25FAF92BAAACQ35962523-63E3F1A5-8C37-4279-BC62-F6530E7CAFAA
P2860
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@ast
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@en
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@nl
type
label
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@ast
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@en
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@nl
prefLabel
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@ast
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@en
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@nl
P50
P921
P1476
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
@en
P2093
Jeanne R Poespoprodjo
P304
P356
10.1016/B978-0-12-397900-1.00003-7
P577
2012-01-01T00:00:00Z